Related Experiment Video
Updated: Sep 26, 2025
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
32.0K
Specific Therapy for T2 Asthma
Diego Bagnasco1,2, Elisa Testino1,2, Stefania Nicola3
1Allergy and Respiratory Diseases, Department of Internal Medicine (DIMI), University of Genoa, 16132 Genoa, Italy.
Journal of Personalized Medicine
|April 23, 2022
Summary
New biological drugs target specific inflammation pathways in severe asthma, offering better symptom control and reduced steroid use. This review details their mechanisms, clinical trial results, and real-world effectiveness.
Area of Science:
- Pulmonology
- Immunology
- Pharmacology
Background:
- Severe asthma affects 10% of patients, often requiring systemic steroids.
- Advances in understanding type 2 inflammation have driven the development of targeted biological therapies.
- Biological drugs offer a new paradigm for managing severe asthma by addressing underlying inflammatory mechanisms.
Purpose of the Study:
- To provide a comprehensive overview of current and emerging biological therapies for severe asthma.
- To analyze the mechanisms of action, clinical trial endpoints, and real-world outcomes of these treatments.
- To discuss current challenges and future directions in the use of biologics for asthma management.
Main Methods:
- Review of clinical trial data and real-world evidence for biologics targeting key inflammatory pathways.
- Analysis of drugs including those targeting IgE, interleukin 5, interleukin 5 receptor alpha, and interleukin 4/13 receptor.
- Exploration of novel biologic targets such as thymic stromal lymphopoietin, interleukin-33, and suppressor of tumorigenicity-2.
Main Results:
- Several biologics (Omalizumab, Mepolizumab, Reslizumab, Benralizumab, Dupilumab) have demonstrated efficacy in controlling severe asthma symptoms and reducing exacerbations.
- Emerging therapies like Tezepelumab, itepekimab, and astegolimab show promise in targeting different inflammatory pathways.
- Real-world data generally support the effectiveness observed in clinical trials, though some usage aspects require further clarification.
Conclusions:
- Biological therapies have significantly advanced the treatment of severe asthma by targeting specific inflammatory pathways.
- A growing arsenal of biologics offers personalized treatment options based on individual patient profiles and inflammatory endotypes.
- Continued research is essential to optimize the use of these drugs and address remaining clinical questions.
Related Concept Videos
01:30Asthma-IV: Diagnostic and Management
2.7K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.7K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
512
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
512
01:26Asthma-II: Pathophysiology and Classification
2.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.9K
01:19Antiasthma Drugs: Leukotriene Modifiers
616
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
616
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
606
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
606
01:20Asthma: Pathogenesis and Management
762
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
762